In 2008, Heimberger et al. [11] for the first time analyzed prognostic impact of Foxp3+ TILs in human glioma based on immunohistochemical staining and reached no statistical significance between 25 patients with Foxp3 presence and 27 ones with Foxp3 absence. This evidence concerns the gene FOXP3 and glioma.